134 related articles for article (PubMed ID: 12224817)
21. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes.
Xiong Y; Fu YF; Fu SH; Zhou HH
J Cardiovasc Pharmacol; 2003 Aug; 42(2):191-6. PubMed ID: 12883321
[TBL] [Abstract][Full Text] [Related]
22. Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy.
Matos JP; de Lourdes Rodrigues M; Ismerim VL; Boasquevisque EM; Genelhu V; Francischetti EA
Clin Nephrol; 2005 Sep; 64(3):180-9. PubMed ID: 16175942
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.
Gamboa JL; Pretorius M; Sprinkel KC; Brown NJ; Ikizler TA
BMC Nephrol; 2015 Oct; 16():167. PubMed ID: 26494370
[TBL] [Abstract][Full Text] [Related]
24. L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes.
Das UN; Repossi G; Dain A; Eynard AR
Front Biosci (Landmark Ed); 2011 Jan; 16(1):13-20. PubMed ID: 21196155
[TBL] [Abstract][Full Text] [Related]
25. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
[TBL] [Abstract][Full Text] [Related]
26. Asymmetric dimethylarginine reduces nitric oxide donor-mediated dilation of arterioles by activating the vascular renin-angiotensin system and reactive oxygen species.
Veresh Z; Debreczeni B; Hamar J; Kaminski PM; Wolin MS; Koller A
J Vasc Res; 2012; 49(4):363-72. PubMed ID: 22652896
[TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
Velkoska E; Warner FJ; Cole TJ; Smith I; Morris MJ
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):49-55. PubMed ID: 19361967
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
Lee YJ; Tsai JC
Metabolism; 2001 Nov; 50(11):1346-50. PubMed ID: 11699055
[TBL] [Abstract][Full Text] [Related]
29. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
[TBL] [Abstract][Full Text] [Related]
30. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Stühlinger MC; Abbasi F; Chu JW; Lamendola C; McLaughlin TL; Cooke JP; Reaven GM; Tsao PS
JAMA; 2002 Mar; 287(11):1420-6. PubMed ID: 11903029
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
32. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
Tropeano AI; Boutouyrie P; Pannier B; Joannides R; Balkestein E; Katsahian S; Laloux B; Thuillez C; Struijker-Boudier H; Laurent S
Hypertension; 2006 Jul; 48(1):80-6. PubMed ID: 16702490
[TBL] [Abstract][Full Text] [Related]
33. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase.
Yasuda S; Miyazaki S; Kanda M; Goto Y; Suzuki M; Harano Y; Nonogi H
Eur Heart J; 2006 May; 27(10):1159-65. PubMed ID: 16627554
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
35. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
36. The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage.
Szlachcic A; Krzysiek-Maczka G; Pajdo R; Targosz A; Magierowski M; Jasnos K; Drozdowicz D; Kwiecien S; Brzozowski T
Curr Pharm Des; 2013; 19(1):90-7. PubMed ID: 22950506
[TBL] [Abstract][Full Text] [Related]
37. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Emonnot L; Cohen R; Lo M
Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571
[TBL] [Abstract][Full Text] [Related]
38. Effect of selected drugs on plasma asymmetric dimethylarginine (ADMA) levels.
Trocha M; Szuba A; Merwid-Lad A; Sozański T
Pharmazie; 2010 Aug; 65(8):562-71. PubMed ID: 20824955
[TBL] [Abstract][Full Text] [Related]
39. A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats.
Fu YF; Xiong Y; Guo Z
Eur J Pharmacol; 2005 Jan; 508(1-3):167-75. PubMed ID: 15680268
[TBL] [Abstract][Full Text] [Related]
40. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
